Anxiety disorders involve dysregulation of the HPA axis, GABAergic signaling, serotonin pathways, and excessive cortisol output. Peptide research approaches anxiety by modulating neurotransmitter balance, dampening hyperactive stress-response circuits, and supporting GABA-A receptor function — without the sedation or dependence risks of benzodiazepines.
1. Selank — Anxiolytic / GABA Modulator
Selank is a synthetic analog of the endogenous peptide tuftsin with well-documented anxiolytic effects. It enhances GABAergic transmission, modulates serotonin and dopamine turnover, and suppresses anxiety-related corticotropin-releasing hormone (CRH) signaling. Selank is particularly notable for reducing anxiety without sedation or cognitive blunting.
Dosing Protocol: 250–500 mcg intranasal (2–3 drops per nostril) once or twice daily. Cycles of 10 days on, 5 days off are common. Can also be administered SubQ at 300–600 mcg daily.
2. Semax — Neuroprotective / Cortisol Modulation
Semax is an ACTH(4-7) analog that modulates HPA axis activity and reduces excessive cortisol output — a primary driver of chronic anxiety. It increases BDNF expression, enhances dopaminergic and serotonergic tone, and improves stress resilience by normalizing the neurochemical response to stressors.
Dosing Protocol: 100–600 mcg intranasal daily (split into morning and midday doses). Start at 100 mcg to assess tolerance. SubQ dosing at 200–500 mcg is also used.
3. BPC-157 — Gut-Brain Axis / Serotonin Regulation
BPC-157 modulates the gut-brain axis, which plays a significant role in anxiety through vagus nerve signaling and gut serotonin production (90% of serotonin is made in the gut). It also directly upregulates dopamine and serotonin receptor sensitivity in limbic brain regions, reducing anxiety-like behavior in multiple animal models.
Dosing Protocol: 250–500 mcg SubQ once daily, or oral BPC-157 (arginate form) 500 mcg to target gut-brain axis directly. Cycle 4–8 weeks.
4. DSIP — Sleep / Stress Recovery
Delta Sleep-Inducing Peptide (DSIP) reduces corticotropin and normalizes diurnal stress hormone rhythms. Chronic anxiety is often perpetuated by disrupted sleep and elevated overnight cortisol — DSIP addresses both by normalizing sleep architecture and dampening the HPA stress response during sleep.
Dosing Protocol: 100–500 mcg SubQ, administered in the evening. Best used on days when sleep disruption is expected. Cycle: 5–10 day courses.
Selank directly quiets the overactive GABAergic/serotonergic anxiety circuitry while Semax normalizes the upstream HPA cortisol response driving chronic stress. BPC-157 addresses the often-overlooked gut-brain serotonin axis, and DSIP restores the sleep architecture needed for full neurochemical recovery. Together they target anxiety from four distinct mechanistic angles.
- Semenova TP et al. (2008). Selank and anxiety-related behavior modulation. Neuroscience and Behavioral Physiology. DOI: 10.1007/s11055-008-0085-3
- Eremin KO et al. (2012). Semax effects on monoamine systems in stress. Biochemistry (Moscow). DOI: 10.1134/S0006297912130093
- Seiwerth S et al. (2018). BPC-157 and stress-induced pathology. Peptides. DOI: 10.1016/j.peptides.2018.10.008
- Graf MV, Kastin AJ. (1986). Delta-sleep-inducing peptide: a review. Neuroscience & Biobehavioral Reviews. DOI: 10.1007/BF02259558
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).